Editas Medicine, Inc. (EDIT) Stock Profile — Insider Trades & Financials

Revenue$24.7M

Net Income-$5.6M

EPS$0.00

Market Cap$301.4M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

James Mullen

CEO & Executive Director

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Founded: 2013
Employees: 226
Headquarters: CAMBRIDGE, MA, United States
Website: www.editasmedicine.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-20.60%

ROA?

-3.01%

D/E Ratio?

5.84

Op. Margin?

-31.34%

📊

Profitability Ratios

Net Margin?

-22.72%

Loading company sections...

Editas Medicine, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades

The morning brief, before the bell.

Editas Medicine, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Recent Congress Trades